Question‐based development of high‐risk medical devices: A proposal for a structured design and review process
暂无分享,去创建一个
K. V. D. van der Bogt | T. Horeman | J. Rotmans | A. Cohen | Nicholas A White | T. J. O. Oude Vrielink
[1] J. Behar,et al. The long‐term outcomes of cardiac implantable electronic devices implanted via the femoral route , 2022, Pacing and clinical electrophysiology : PACE.
[2] R. Redberg,et al. Coverage of Transvenous Pulmonary Embolectomy - Medicare's Missed Opportunity for Evidence Generation. , 2021, The New England journal of medicine.
[3] Jonathan J. Darrow,et al. FDA Regulation and Approval of Medical Devices: 1976-2020. , 2021, JAMA.
[4] M D Kruizinga,et al. Development of Novel, Value-Based, Digital Endpoints for Clinical Trials: A Structured Approach Toward Fit-for-Purpose Validation , 2020, Pharmacological Reviews.
[5] M. Kenter,et al. Integrating scientific considerations into R&D project valuation , 2019, Nature Biotechnology.
[6] A. Cohen,et al. The Future of Clinical Trial Design: The Transition from Hard Endpoints to Value-Based Endpoints. , 2019, Handbook of experimental pharmacology.
[7] Licia Di Pietro,et al. Safe innovation: On medical device legislation in Europe and Africa , 2018, Health Policy and Technology.
[8] C. Breder,et al. Regulatory watch: The target product profile as a tool for regulatory communication: advantageous but underused , 2017, Nature Reviews Drug Discovery.
[9] Cinzia Greco. The Poly Implant Prothèse breast prostheses scandal: Embodied risk and social suffering. , 2015, Social science & medicine.
[10] J. V. van Gerven,et al. The use of biomarkers in human pharmacology (Phase I) studies. , 2015, Annual review of pharmacology and toxicology.
[11] M. Mack,et al. Medical device innovation: prospective solutions for an ecosystem in crisis. Adding a professional society perspective. , 2012, JACC. Cardiovascular interventions.
[12] C. Heneghan. The saga of Poly Implant Prosthèse breast implants , 2012, BMJ : British Medical Journal.
[13] J. Kärrholm,et al. RSA and registries: the quest for phased introduction of new implants. , 2011, The Journal of bone and joint surgery. American volume.
[14] D. Cohen. Out of joint: The story of the ASR , 2011, BMJ : British Medical Journal.
[15] A. Cohen. Developing drug prototypes: pharmacology replaces safety and tolerability? , 2010, Nature Reviews Drug Discovery.
[16] Gregory L Herr. Biodesign: the process of innovating medical technologies. , 2010, Biomedical instrumentation & technology.
[17] Lauren Aquino Shluzas,et al. Stage-Gate Process for the Development of Medical Devices , 2009 .
[18] William J. Blot,et al. Twenty-Five–Year Experience With the Björk-Shiley Convexoconcave Heart Valve: A Continuing Clinical Concern , 2005, Circulation.
[19] Samuel Jacob,et al. A question based approach to drug development , 2003 .
[20] C. Gluud. Trials and errors in clinical research , 1999, The Lancet.
[21] L B Sheiner,et al. Learning versus confirming in clinical drug development , 1997, Clinical pharmacology and therapeutics.
[22] ICH guideline E8 (R1) on general considerations for clinical studies , 2021 .